System Certification ISO 9001:2000
Exbio Antibodies CZ / SK eShop
by categories | a-z list | Application type: Flow Cytometry | Immunohistochemistry | Functional Studies

Mouse Monoclonal to CD324 / E-Cadherin

67A4 (IgG1)

Technical Information Request    Inquiry for Bulk Prices

Product No. Form Quantity Stock Price Datasheet Shop
  11-588-C025 purified 0.025 mg yes choose region PDF datasheetHTML datasheet buy
  11-588-C100 purified 0.1 mg yes choose region PDF datasheetHTML datasheet buy
  1F-588-T025 FITC 25 tests yes choose region PDF datasheetHTML datasheet buy
  1F-588-T100 FITC 100 tests yes choose region PDF datasheetHTML datasheet buy
  1P-588-T025 PE 25 tests yes choose region PDF datasheetHTML datasheet buy
  1P-588-T100 PE 100 tests yes choose region PDF datasheetHTML datasheet buy
  1A-588-T025 APC 25 tests yes choose region PDF datasheetHTML datasheet buy
  1A-588-T100 APC 100 tests yes choose region PDF datasheetHTML datasheet buy
- In stock! Ready for immediate despatch - Manufacture on order


CD324 / E-cadherin is an epithelial cell surface molecule, which provides calcium-dependent homophilic interactions with E-cadherin of another cell. These intaractions take part in morphogenetic programs controlling the maintenance of the structural and functional integrity of epithelia and affect invasive potential of epithelial neoplasms. CD324 / E-cadherin is implicated in cell growth and differentiation, cell recognition, and sorting during developmental morphogenesis, as well as in aggregation-dependent cell survival. CD324 / E-cadherin-mediated cell adhesion system is highly regulated from inside the cell by a number of intracellular signaling pathways.


The mouse monoclonal antibody 67A4 recognizes CD324 / E-cadherin, an approximately 100 kDa epithelial cell adhesion molecule, whose detection is important for determination of invasive potential of epithelial neoplasms.

Regulatory Status


T-47D cells

Species Reactivity:

  • Human

Negative Species:


  • Flow Cytometry
    Application note:Tested on cell lines CACO-2 and HT-29. In this case the recommended concentration is 5-10 μg/ml per 1 million cells/ml.
  • Immunoprecipitation
  • Western Blotting
  • Immunohistochemistry (frozen sections)
    Recommended dilution:4-8 μg/ml
    Positive tissue:tonsil
  • Immunocytochemistry
Usage note:
Indicated dilutions are recommended starting points for use of this product. Working concentrations should be determined by the investigator.

General references

  • *Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991 Mar 22;251(5000):1451-5. [Abstract]
  • *Pece S, Chiariello M, Murga C, Gutkind JS: Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem. 1999 Jul 2;274(27):19347-51. [Abstract] [Full Text]
  • *Pece S, Gutkind JS: Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem. 2000 Dec 29;275(52):41227-33. [Abstract] [Full Text]
  • Product Specific References

  • *Armeanu S, Bühring HJ, Reuss-Borst M, Müller CA, Klein G: E-cadherin is functionally involved in the maturation of the erythroid lineage. J Cell Biol. 1995 Oct;131(1):243-9. [Abstract] [Full Text]
  • *Bühring HJ, Müller T, Herbst R, Cole S, Rappold I, Schuller W, Zhu X, Fritzsch U, Faul C, Armeanu S, Ullrich A, Klein G, Schmidt H: The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages. Leukemia. 1996 Jan;10(1):106-16. [Abstract]
  • *Novak N, Kraft S, Haberstok J, Geiger E, Allam P, Bieber T: A reducing microenvironment leads to the generation of FcepsilonRIhigh inflammatory dendritic epidermal cells (IDEC). J Invest Dermatol. 2002 Oct;119(4):842-9. [Abstract] [Full Text]
  • *Servet-Delprat C, Vidalain PO, Bausinger H, Manié S, Le Deist F, Azocar O, Hanau D, Fischer A, Rabourdin-Combe C: Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol. 2000 Feb 15;164(4):1753-60. [Abstract] [Full Text]
  • *Furio L, Guezennec A, Ducarre B, Guesnet J, Peguet-Navarro J: Differential effects of allergens and irritants on early differentiating monocyte-derived dendritic cells. Eur J Dermatol. 2008 Mar-Apr;18(2):141-7. [Abstract] [Full Text]
  • *Robertson H, Ali S, McDonnell BJ, Burt AD, Kirby JA: Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol. 2004 Feb;15(2):390-7. [Abstract] [Full Text]
  • *Kutlesa S, Wessels JT, Speiser A, Steiert I, Müller CA, Klein G: E-cadherin-mediated interactions of thymic epithelial cells with CD103+ thymocytes lead to enhanced thymocyte cell proliferation. J Cell Sci. 2002 Dec 1;115(Pt 23):4505-15. [Abstract] [Full Text]
  • *Caberg JH, Hubert PM, Begon DY, Herfs MF, Roncarati PJ, Boniver JJ, Delvenne PO: Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis. 2008 Jul;29(7):1441-7. [Abstract] [Full Text]
  • *Lin JC, Liao SK, Lee EH, Hung MS, Sayion Y, Chen HC, Kang CC, Huang LS, Cherng JM. Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome. J Biomed Sci. 2009 Nov 24;16:105. [Abstract] [Full Text]
  • *And many other.
  • For research use only. Not for drug, diagnostic or other use.

    Example Data

    67A4 PE

    Fig. 1. Surface staining of HT-29 / SP2 cells with anti-CD324 (67A4) PE.

    67A4 APC

    Fig. 2. Surface staining of HT-29 / SP2 cells with anti-CD324 (67A4) APC.


    Fig. 3. Surface staining of HT-29 cells with anti-CD324 (67A4) FITC.

    Unless indicated otherwise, all products are For Research Use Only and not for diagnostic or therapeutic use. Not for resale or transfer either as a stand-alone product or as a component of another product without written consent of EXBIO. EXBIO will not be held responsible for patent infringement or other violations that may occur with the use of our products. All orders are accepted subject to EXBIO´s term and conditions which are available at
    © 2003 EXBIO. All rights reserved.
    terms and conditions | privacy policy